Related references
Note: Only part of the references are listed.An Update on African Trypanocide Pharmaceutics and Resistance
Keneth Iceland Kasozi et al.
FRONTIERS IN VETERINARY SCIENCE (2022)
Structure of trypanosome coat protein VSGsur and function in suramin resistance
Johan Zeelen et al.
NATURE MICROBIOLOGY (2021)
Physiological and proteomic profiles of Trypanosoma brucei rhodesiense parasite isolated from suramin responsive and non-responsive HAT patients in Busoga, Uganda
Catherine N. Mutuku et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2021)
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
Victor Kande Betu Ku Mesu et al.
Lancet Global Health (2021)
Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018
Jose R. Franco et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
A Trypanosoma brucei ORFeome-Based Gain-of-Function Library Identifies Genes That Promote Survival during Melarsoprol Treatment
McKenzie Carter et al.
MSPHERE (2020)
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
Emily A. Dickie et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2020)
Potent Antitrypanosomal Activities of 3-Aminosteroids against African Trypanosomes: Investigation of Cellular Effects and of Cross-Resistance with Existing Drugs
Charles O. Nnadi et al.
MOLECULES (2019)
Expression of a specific variant surface glycoprotein has a major impact on suramin sensitivity and endocytosis in Trypanosoma brucei
Natalie Wiedemar et al.
FASEB BIOADVANCES (2019)
Fexinidazole for the treatment of human African trypanosomiasis
A. H. Fairlamb
DRUGS OF TODAY (2019)
Prevalence of hemoprotozoan parasites in small ruminants along a human-livestock-wildlife interface in western Uganda
Keneth Iceland Kasozi et al.
VETERINARY PARASITOLOGY- REGIONAL STUDIES AND REPORTS (2019)
Beyond immune escape: a variant surface glycoprotein causes suramin resistance in Trypanosoma brucei
Natalie Wiedemar et al.
MOLECULAR MICROBIOLOGY (2018)
Melarsoprol Resistance in African Trypanosomiasis
Alan H. Fairlamb et al.
TRENDS IN PARASITOLOGY (2018)
The Long Wait for a New Drug for Human African Trypanosomiasis
Catriona H. Baker et al.
TRENDS IN PARASITOLOGY (2018)
Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity
Laura Jeacock et al.
PLOS PATHOGENS (2017)
Impact of mass chemotherapy in domestic livestock for control of zoonotic T-b. rhodesiense human African trypanosomiasis in Eastern Uganda
Jenna Fyfe et al.
ACTA TROPICA (2017)
Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei
Susan Wyllie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense
Fabrice E. Graf et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Whole genome sequencing shows sleeping sickness relapse is due to parasite regrowth and not reinfection
Joshua B. Richardson et al.
EVOLUTIONARY APPLICATIONS (2016)
The animal trypanosomiases and their chemotherapy: a review
Federica Giordani et al.
PARASITOLOGY (2016)
Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo
Patient Pati Pyana et al.
INFECTION GENETICS AND EVOLUTION (2015)
Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein
Jane C. Munday et al.
MOLECULAR MICROBIOLOGY (2015)
Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
Fabrice E. Graf et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Reproducibility in Science Improving the Standard for Basic and Preclinical Research
C. Glenn Begley et al.
CIRCULATION RESEARCH (2015)
Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs
Jane C. Munday et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo
Patient Pyana Pati et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Domestic pigs as potential reservoirs of human and animal trypanosomiasis in Northern Tanzania
Louise C. Hamill et al.
PARASITES & VECTORS (2013)
A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis
Peter Babokhov et al.
PATHOGENS AND GLOBAL HEALTH (2013)
Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol
Fabrice E. Graf et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Chemotherapy for second-stage Human African trypanosomiasis
Vittoria Lutje et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Drug resistance in human African trypanosomiasis
Michael P. Barrett et al.
FUTURE MICROBIOLOGY (2011)
Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
Nicola Baker et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters
Gabriela Schumann Burkard et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Cross-Resistance to Nitro Drugs and Implications for Treatment of Human African Trypanosomiasis
Antoaneta Y. Sokolova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Diverse Effects on Mitochondrial and Nuclear Functions Elicited by Drugs and Genetic Knockdowns in Bloodstream Stage Trypanosoma brucei
Christal Worthen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Isabel M. Vincent et al.
PLOS PATHOGENS (2010)
Pentamidine Movement across the Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers: Effect of Trypanosome Infection, Combination Therapy, P-Glycoprotein, and Multidrug Resistance-Associated Protein
Lisa Sanderson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Genotypic Status of the TbAT1/P2 Adenosine Transporter of Trypanosoma brucei gambiense Isolates from Northwestern Uganda following Melarsoprol Withdrawal
Anne J. N. Kazibwe et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes
Harry P. de Koning
TRENDS IN PARASITOLOGY (2008)
Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance
Sonja C. Bernhard et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Detection of mutant P2 adenosine transporter (TbAT1) gene in Trypanosoma brucei gambiense isolates from northwest Uganda using allele-specific polymerase chain reaction
Barbara Nerima et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate
Naomi Maina et al.
ACTA TROPICA (2007)
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes
Daniel J. Bridges et al.
MOLECULAR PHARMACOLOGY (2007)
Drugs and drug resistance in African trypanosomiasis
Vincent Delespaux et al.
DRUG RESISTANCE UPDATES (2007)
Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance
Charlotte A. Lanteri et al.
MOLECULAR PHARMACOLOGY (2006)
Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo
Manica Balasegaram et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2006)
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo
Manica Balasegaram et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2006)
A proteomic analysis of arsenical drug resistance in Trypanosoma brucei
Aude L. Foucher et al.
PROTEOMICS (2006)
Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania
SN Kibona et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Molecular pharmacology of adenosine transport in Trypanosoma brucei:: P1/P2 revisited
F Geiser et al.
MOLECULAR PHARMACOLOGY (2005)
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei
E Matovu et al.
EUKARYOTIC CELL (2003)
Pentamidine uptake and resistance in pathogenic protozoa: past, present and future
PG Bray et al.
TRENDS IN PARASITOLOGY (2003)
Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis
B Mpia et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2002)
The phenomenon of treatment failures in Human African Trypanosomiasis
R Brun et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy
E Matovu et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda
EM Fèvre et al.
LANCET (2001)
Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle
E Matovu et al.
MICROBES AND INFECTION (2001)
Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment
C Burri et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Melarsoprol refractory T-b. gambiense from Omugo, north-western Uganda
E Matovu et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Transporters in African trypanosomes: role in drug action and resistance
HP de Koning
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2001)
Share Paper
